Phthisiology questions in International Congress of the European Respiratory Society 2019: achievement of the Ukrainian scientists
Abstract. The program of the International Congress of the European Respiratory Society (ERS) in 2019 covered the key topics of respiratory medicine. One of Congress’s leading issues has been tuberculosis, which is one of the world’s major threats to humanity. Since 1995, WHO has documented a TB epidemic in Ukraine and today this problem is urgent in our country.
Aim. To analyze tuberculosis information at the 2019 ERS International Congress, with a summary of the phthisiology abstracts presented by Ukrainian scientists at this event.
Materials and methods. The data regarding the abstracts of scientific reports were obtained from the Congress website and the online program of the personal account of an ERS member, doctor of medical sciences, professor Gumeniuk Galyna.
Results. Tuberculosis issues were discussed daily in Congress in the form of symposia, expert meetings, thematic and poster discussions and oral presentations. In total, 201 short messages were addressed at the 2019 ERS Congress of Phthisiology, including 7 abstracts (3.5 %) owned by Ukrainian scientists.
Conclusions. Ukrainian phthisiologists actively participated in the work of the Congress ERS 2019. Topics presented by national scientists reports (epidemiology, treatment of tuberculosis with drug resistance, including patients with HIV infection, predicting the effectiveness of treatment, prevention of adverse events and concomitant to tuberculosis disorders) meets the global challenges of tuberculosis in the world.
Feshchenko YI. Modern tendencies of studying of problems of tuberculosis. Ukr. pulmonol. J.2019; 1: 8-24. DOI: 10.312.15/2306-4927-2019-103-1-8-24.
About ERS2019. Available from: https://erscongress.org/about-ers‑2019.html (last accessed 31.10.2019).
Bothamley GH, Andre E, Kuksa L, Barkana L, Keane J, Veziris N, Crevel R Van, Magis-Escurra C, Jankovic M, Schoch O, Zellweger J, Vasankari T, Eyuboglu F, Holland R, Normark J, Macedo R, Korzeniewska M, Nanovoc Z, Butov D, et al. National advisory services for multidrug-resistant tuberculosis (MDRTB) in Europe: an ERS-TBnet survey. Eur Respir J. 2019; 54 (Suppl63): 3076.
Butov D, Feshchenko Y, Kuzhko M, Gumenuik M, Yurko K, Tkachenko A, Nekrasova N, Gulchuk N, Tlustova T, Butova T. Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment. Eur Respir J. 2019; 54 (Suppl63): 269.
Exhibition Floorplan ERS International Congress 2019. Available from: https://erscongress.org/images/congress‑2019/Industry/ ERS19_Madrid_Exhibitors_List_Plan.pdf (last accessed 29.10.2019).
Frankvan L, Brinkmann F, Cirillo DM, Dheda K, Duarte R, et al. The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation. Eur Respir J. 2019; 53 (1): 1802089. DOI: 10.1183/13993003.02089-2018.
Global Tuberculosis Report 2019. Latest status of the tuberculosis epidemic. WHO. Available from: https://www.who.int/tb/globalreport‑2019 (last accessed 29.11.2019).
Konstantynovska O, Liashenko O, Poteiko P, Rohozhyn A, Hrek I, Solodiankin O. Comparative analysis and epidemiological aspects of spreading tuberculosis strains in Kharkiv region, Eastern Ukraine. Eur Respir J. 2019; 54 (Suppl63): 820.
Lytvynenko N, Pogrebna M, Senko J, Protsyk L, Chobotar O, Grankina N, Gumeniuk M. Short 12-month regimen with intravenous linezolid for pre-XDR TB: treatment outcomes and 24 months follow-up results. Eur Respir J. 2019; 54 (Suppl63): 5584.
Primary care at the ERS Congress. Available from: https://erscongress.org/programme‑2019/146-programme/659-primary-care.html (last accessed 31.10.2019).
Programme ERS International Congress 2019. Available from: https://erscongress.org/programme‑2019.html (last accessed 31.10.2019).
Programme highlights. Available from: https://erscongress.org/programme‑2019/highlights.html (last accessed 31.10.2019).
Semianiv I, Todoriko L, Sprynsian T, Semianiv M. Predicting the efficiency of the treatment of drug-resistant tuberculosis depending on the polymorphism variation of glutathione-S-transferase genes. Eur Respir J. 2019; 54 (Suppl63): 1193.
Semianiv I, Todoriko L, Sprynsian T, Yeremenchuk I. Prevention of adverse reactions due to pharmacotherapy in MRTB considering polymorphism of glutathione-S-transferase M1 and T1genes. Eur Respir J. 2019; 54 (Suppl63): 1179.
Shvets O. Dynamics of carbohydrate metabolism in patients with destructive pulmonary tuberculosis. Eur Respir J. 2019; 54 (Suppl63): 3265.
Statistics ERS International Congress 2019. Available from: https://erscongress.org/images/congress‑2020/Industry/ ERS2019_Statistics.pdf (last accessed 29.10.2019).
Tuberculosis surveillance and monitoring report in Europe 2019. WHO Regional Office for Europe (WHO/Europe) and the European Centre for Disease Prevention and Control (ECDC). Available from: http://www.euro.who.int/en/publications/abstracts/tuberculosis-surveillance-and-monitoring-report-in-europe‑2019 (last accessed 29.11.2019).
This work is licensed under a Creative Commons Attribution 4.0 International License.